Search Results

You are looking at 41 - 50 of 94 items for :

  • "pain management" x
Clear All
Full access

Robert W. Carlson

evaluation and treatment of squamous cell carcinoma of the vulva and include principles of surgery, principles of radiation therapy, and systemic therapy. Among the supportive care sessions this year was “Cancer Pain Management: Strategies for Safe and

Full access

689 0140685 10.6004/jnccn.2016.0193 Understanding and Utilizing Patient Preferences in Cancer Treatment Decisions Ubel Peter A. MD 5 2016 14 14 5S 5S 691 691 693 693 0140691 10.6004/jnccn.2016.0194 Cancer Pain Management: Strategies for

Full access

Mandy R. Sakamoto, Megan Eguchi, Christine M. Azelby, Jennifer R. Diamond, Christine M. Fisher, Virginia F. Borges, Cathy J. Bradley and Peter Kabos

likely to receive opioids at 3 months after treatment. These disparities may be partly explained by financial and environmental barriers experienced by minority groups that impair long-term pain management. 53 Furthermore, although non-White patients

Full access

“The NCCN Value Initiative: Using NCCN Evidence Blocks in Clinical Decisions.” As opioid abuse in the face of chronic pain becomes a major health concern, pain management for people with cancer is a challenge for providers. Judith Paice, PhD, RN

Full access

6 7 MD, MPH Davidson Nancy E. 1 2 3 MD Liu Catherine 1 6 7 MD Stewart F. Marc 1 2 3 MD 04 2020 18 18 4 4 366 366 369 369 jnccnCOVID1804 10.6004/jnccn.2020.7560 Bridging the Gap Among Clinical Practice Guidelines for Pain Management in Cancer and

Full access

Tara B. Sanft and Jamie H. Von Roenn

inpatient oncology service . Clin J Oncol Nurs 2007 ; 11 : 687 – 695 . 41 Von Roenn JH Cleeland CS Gonin R . Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group . Ann Intern Med

Full access

Omar Abdel-Rahman, Hatim Karachiwala and Jacob C. Easaw

Background Opioid analgesia is an integral part of pain management among patients with advanced cancer. 1 , 2 A potential correlation between opioid analgesics and cancer progression has been previously hypothesized. 3 , 4 However, most of the

Full access

Jimmie C. Holland, Mark Lazenby and Matthew J. Loscalzo

, using a principle successful in pain management, the panel recommended asking patients, “How is your distress level on a scale of 0 to 10?” Distress is normal among people with cancer, and patients have come to accept the term. This simple question has

Full access

Juan P. Cata and Daniel D. Kim

opioids because of the 2 enantiomers’ synergistic analgesic actions. 10 Furthermore, tramadol is recommended by the WHO for step 2 in the ladder for cancer pain management, and is considered an opioid with a low risk of misuse or abuse in Europe and the

Full access

coordination of care, pain management during an opioid crisis, biosimilars, cancer-associated distress, biomarkers, genetic testing, and appropriate transition to end-of-life care. The keynote session highlighted the benefits and challenges of treatment with